Telo Genomics Balance Sheet Health

Financial Health criteria checks 4/6

Telo Genomics has a total shareholder equity of CA$590.1K and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$965.6K and CA$375.6K respectively.

Key information

0%

Debt to equity ratio

CA$0

Debt

Interest coverage ration/a
CashCA$796.02k
EquityCA$590.06k
Total liabilitiesCA$375.59k
Total assetsCA$965.64k

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: TELO's short term assets (CA$919.0K) exceed its short term liabilities (CA$375.6K).

Long Term Liabilities: TELO has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: TELO is debt free.

Reducing Debt: TELO currently has no debt however we can't compare to 5 years ago as we have no data for that period.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: TELO has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: TELO has less than a year of cash runway if free cash flow continues to reduce at historical rates of 13.2% each year


Discover healthy companies